Cargando…

Go with the Flow—Early Assessment of Measurable Residual Disease in Children with Acute Lymphoblastic Leukemia Treated According to ALL IC-BFM2009

SIMPLE SUMMARY: Monitoring of residual disease is a very important aspect of modern treatment approaches in many types of cancer. In acute leukemias in both children and adults, molecular and cytometric methods are used to assess the burden of leukemia at different points during therapy. Residual di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pawinska-Wasikowska, Katarzyna, Bukowska-Strakova, Karolina, Surman, Marta, Rygielska, Monika, Sadowska, Beata, Ksiazek, Teofila, Klekawka, Tomasz, Wieczorek, Aleksandra, Skoczen, Szymon, Balwierz, Walentyna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653819/ https://www.ncbi.nlm.nih.gov/pubmed/36358778 http://dx.doi.org/10.3390/cancers14215359

Ejemplares similares

Blinatumomab as a Bridge Therapy for Hematopoietic Stem Cell Transplantation in Pediatric Refractory/Relapsed Acute Lymphoblastic Leukemia
por: Pawinska-Wasikowska, Katarzyna, et al.
Publicado: (2022)

Disseminated Juvenile Xanthogranuloma and Hemophagocytic Lymphohistiocytosis Developed During Treatment of Acute Lymphoblastic Leukemia: Case Report
por: Pawińska-Wa̧sikowska, Katarzyna, et al.
Publicado: (2020)

Segmental chromosomal aberrations as the poor prognostic factor in children over 18 months with stage 3 neuroblastoma without MYCN amplification
por: Wieczorek, Aleksandra, et al.
Publicado: (2023)

Monitoring of treatment with L-asparaginase in children with acute lymphoblastic leukaemia, with a focus on silent inactivation and its influence on the treatment outcome
por: Czogala, Malgorzata, et al.
Publicado: (2022)

Polymorphisms of SLC19A1 80 G>A, MTHFR 677 C>T, and Tandem TS Repeats Influence Pharmacokinetics, Acute Liver Toxicity, and Vomiting in Children With Acute Lymphoblastic Leukemia Treated With High Doses of Methotrexate
por: Cwiklinska, Magdalena, et al.
Publicado: (2020)

Dinutuximab beta combined with chemotherapy in patients with relapsed or refractory neuroblastoma
por: Wieczorek, Aleksandra, et al.
Publicado: (2023)

The role of N-Myc gene amplification in neuroblastoma childhood tumour – single-centre experience
por: Kaczówka, Przemysław, et al.
Publicado: (2018)

PB1747: OUTCOME OF CHILDHOOD ALLTREATED WITH ALL BFM IC 2009 PROTOCOL
por: Çilsaat, Gizem, et al.
Publicado: (2023)

Dinutuximab Beta Maintenance Therapy in Patients with High-Risk Neuroblastoma in First-Line and Refractory/Relapsed Settings—Real-World Data
por: Wieczorek, Aleksandra, et al.
Publicado: (2023)

Long‐term treatment results of Polish pediatric and adolescent patients enrolled in the ALL IC‐BFM 2002 trial
por: Kowalczyk, Jerzy R., et al.
Publicado: (2019)

Role of HMOX1 Promoter Genetic Variants in Chemoresistance and Chemotherapy Induced Neutropenia in Children with Acute Lymphoblastic Leukemia
por: Bukowska-Strakova, Karolina, et al.
Publicado: (2021)

Late effects in survivors of childhood acute lymphoblastic leukemia in the context of selected gene polymorphisms
por: Kwiecinska, Kinga, et al.
Publicado: (2018)

Genetic Profiling in Children With Acute Lymphoblastic Leukemia Referred for Allogeneic Hematopoietic Stem Cell Transplantation
por: Kwiecinska, Kinga, et al.
Publicado: (2022)

Pediatric Acute Myeloid Leukemia Post Cytotoxic Therapy—Retrospective Analysis of the Patients Treated in Poland from 2005 to 2022
por: Czogała, Małgorzata, et al.
Publicado: (2023)

Treatment Outcome and the Genetic Characteristics of Acute Promyelocytic Leukemia in Children in Poland From 2005 to 2018
por: Czogała, Małgorzata, et al.
Publicado: (2020)

Advances in the First Line Treatment of Pediatric Acute Myeloid Leukemia in the Polish Pediatric Leukemia and Lymphoma Study Group from 1983 to 2019
por: Czogała, Małgorzata, et al.
Publicado: (2021)

Characteristics and Outcome of FLT3-ITD-Positive Pediatric Acute Myeloid Leukemia—Experience of Polish Pediatric Leukemia and Lymphoma Study Group from 2005 to 2022
por: Czogała, Małgorzata, et al.
Publicado: (2023)

Case Report: Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Application in Intraperitoneally Disseminated Inflammatory Myofibroblastic Tumor and in the Youngest Patient in the World: New Indication and Modification of Technique
por: Garnier, Hanna, et al.
Publicado: (2021)

Day 15 and Day 33 Minimal Residual Disease Assessment for Acute Lymphoblastic Leukemia Patients Treated According to the BFM ALL IC 2009 Protocol: Single-Center Experience of 133 Cases
por: Radu, Letitia-Elena, et al.
Publicado: (2020)

The Role of Id2 Protein in Neuroblatoma in Children
por: Wieczorek, Aleksandra, et al.
Publicado: (2015)

Genetic Signature of Acute Lymphoblastic Leukemia and Netherton Syndrome Co-incidence—First Report in the Literature
por: Skoczen, Szymon, et al.
Publicado: (2020)

Comparison of blood pressure values and expression of genes associated with hypertension in children before and after hematopoietic cell transplantation
por: Strojny, Wojciech, et al.
Publicado: (2021)

High Frequency of Fusion Gene Transcript Resulting From t(10;11)(p12;q23) Translocation in Pediatric Acute Myeloid Leukemia in Poland
por: Ksiazek, Teofila, et al.
Publicado: (2020)

Polyneuropathy in Acute Lymphoblastic Leukemia Long-Term Survivors: Clinical and Electrophysiological Characteristics With the Impact of Radiotherapy
por: Kroczka, Slawomir, et al.
Publicado: (2021)

Plasma levels of leptin and soluble leptin receptor and polymorphisms of leptin gene -18G > A and leptin receptor genes K109R and Q223R, in survivors of childhood acute lymphoblastic leukemia
por: Skoczen, Szymon, et al.
Publicado: (2011)

Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study
por: Rizzari, Carmelo, et al.
Publicado: (2019)

Retrospective Analysis of the Treatment Outcome in Myeloid Leukemia of Down Syndrome in Polish Pediatric Leukemia and Lymphoma Study Group From 2005 to 2019
por: Czogala, Malgorzata, et al.
Publicado: (2020)

Clinical Utility of Ammonia Concentration as a Diagnostic Test in Monitoring of the Treatment with L-Asparaginase in Children with Acute Lymphoblastic Leukemia
por: Czogała, Małgorzata, et al.
Publicado: (2014)

Incidence and Characteristics of Hypersensitivity Reactions to PEG-asparaginase Observed in 6136 Children With Acute Lymphoblastic Leukemia Enrolled in the AIEOP-BFM ALL 2009 Study Protocol
por: Rizzari, Carmelo, et al.
Publicado: (2023)

PEG-asparaginase in BFM-90 regimen improves outcomes in adults with newly diagnosed lymphoblastic lymphoma
por: Zheng, Wen, et al.
Publicado: (2017)

The impact of donor type on the outcome of pediatric patients with very high risk acute lymphoblastic leukemia. A study of the ALL SCT 2003 BFM-SG and 2007-BFM-International SG
por: Dalle, Jean-Hugues, et al.
Publicado: (2020)

Cost-utility of Protocols of BFM-ALL and UK-ALL for Treatment of Children with Acute Lymphoblastic Leukemia in Iran
por: HAYATI, Hadi, et al.
Publicado: (2018)

Survival and prognostic analysis of T-cell lymphoblastic lymphoma patients treated with dose-adjusted BFM-90 regimen
por: Yu, Hui, et al.
Publicado: (2022)

Isolated central nervous system relapses in patients with high-risk neuroblastoma -clinical presentation and prognosis: experience of the Polish Paediatric Solid Tumours Study Group
por: Wieczorek, Aleksandra, et al.
Publicado: (2022)

The Malposition of Central Venous Catheters in Children
por: Dzierzega, Maria, et al.
Publicado: (2014)

Genetic Background of Immune Complications after Allogeneic Hematopoietic Stem Cell Transplantation in Children
por: Skoczen, Szymon, et al.
Publicado: (2016)

PB1733: LONG-TERM FOLLOW-UP FOR PATIENTS WITH T CELL LYMPHOBLASTIC LYMPHOMA/ ACUTE LYMPHOBLASTIC LEUKEMIA WHO RECEIVED MODIFIED BFM PROTOCOLS
por: Gao, Yan, et al.
Publicado: (2023)

miR-125b predicts childhood acute lymphoblastic leukaemia poor response to BFM chemotherapy treatment
por: Piatopoulou, Despina, et al.
Publicado: (2017)

Development of treatment and clinical results in childhood acute myeloid leukemia in Poland
por: Balwierz, Walentyna, et al.
Publicado: (2012)

Invasive fungal diseases impact on outcome of childhood ALL – an analysis of the international trial AIEOP-BFM ALL 2009
por: Lehrnbecher, Thomas, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6frj3h8u0r28u42c2ro72ntuic